Area of research
Physiology · Epidemiology
Research interest
Research interests include Adipose Tissue and Metabolism, Liver Disease Diagnosis and Treatment, Lipid metabolism and biosynthesis, and Metabolism, Diabetes, and Cancer.
Lysophosphatidic acid triggers inflammation in the liver and white adipose tissue in rat models of 1-acyl-sn-glycerol-3-phosphate acyltransferase 2 deficiency and overnutrition
Anti‐inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid‐induced insulin resistance
Adipose glucocorticoid action influences whole‐body metabolism <i>via</i> modulation of hepatic insulin action
Author Correction: Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
Acetyl‐CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents
Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes
Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome
Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance
XBP1s Is an Anti-lipogenic Protein
Imeglimin lowers glucose primarily by amplifying glucose-stimulated insulin secretion in high-fat-fed rodents
Argininosuccinate synthetase regulates hepatic AMPK linking protein catabolism and ureagenesis to hepatic lipid metabolism
Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes
Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic–pituitary–adrenal axis
Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5)
Second‐generation antisense oligonucleotides against β‐catenin protect mice against diet‐induced hepatic steatosis and hepatic and peripheral insulin resistance
Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis
Tissue-Specific Differences in the Development of Insulin Resistance in a Mouse Model for Type 1 Diabetes
Muscle-specific activation of Ca2+/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice
Reversal of Hypertriglyceridemia, Fatty Liver Disease, and Insulin Resistance by a Liver-Targeted Mitochondrial Uncoupler
Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance
Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats